It has been shown that CD40 is required for optimal B cell activation. Casitas-B-lineage lymphoma-b (Cbl-b), a RING finger E3 ubiquitin ligase, inhibits B cell activation. In this report, we demonstrate that CD40 stimulation markedly enhances IgM-induced B cell proliferation in wild-type (WT) mice, whereas this cell proliferation was reduced in CD40-deficient (Cd40 
Introduction
It has been documented that autoreactive B cells can be regulated via the induction of a state of hyporesponsiveness or anergy [1] [2] [3] . In this mechanism of tolerance, autoreactive B cells are inactivated so that they fail to participate in an immune response. The breakdown of peripheral B cell tolerance leads to the development of autoimmune disease [1] , and it has been reported that autoreactive B cells become activated if they receive help from T cells. Similar to T cells, optimal B cell activation requires two signals [4] . The autoreactive B cells encounter their antigens (Ags) in the periphery (signal 1) and, if provided with T cell help (signal 2), are activated to produce antibody (Ab) [2] [3] [4] . However, if the autoreactive B cells do not receive T cell help (i.e., they receive signal 1 without signal 2), an overall anergic state ensues [2, 4] . CD40 plays an essential role in this process as blocking CD40 − CD40 ligand (CD40L) interaction suppresses the follicular entry of autoreactive B cells [4] . The interaction of CD40 on B cells with the CD40L on activated CD4 + T cells is the key process in the initiation of Ab responses to T-dependent Ags [5] . BCR or CD40 stimulation is weakly mitogenic alone, while signals generated through CD40, together with BCR, synergistically unleash the program of activation and proliferation of B cells, isotype switching, germinal center (GC) formation, and B cell memory development [3, 6, 7] . It has also been shown that high-affinity rheumatoid factor production by autoreactive B cells in rheumatoid arthritis is dependent on CD40 − CD40L interaction [8] . The critical role of CD40 in autoimmunity is supported by the fact that Cd40 −/− mice are resistant to several models of autoimmune diseases [9, 10] . Cbl-b, a RING finger E3 ubiquitin ligase, consists of a phosphotyrosine-binding domain (PTB), a RING finger domain, a C-terminal proline-rich region with potential tyrosine phosphorylation sites, and a ubiquitin-associated region (UBA) [11] [12] [13] . We and others have demonstrated that CD28 controls the threshold for T cell activation by targeting Cbl-b for ubiquitination [14] [15] [16] , which is mediated by protein tyrosine phosphatase SHP-1 or PKC-θ [16, 17] . In B cells, Cbl-b has been shown to inhibit CD40-induced B cell responses by hindering the recruitment of TRAF-2 to CD40, thus attenuating CD40-mediated NF-κB and JNK activation [6] . Whether Cbl-b also controls the B cell activation threshold is currently unknown.
In this study, we show that BCR/CD40 costimulation induces stronger ubiquitination and degradation of Cbl-b than that of BCR stimulation alone. Consistent with this finding, BCR-induced Cbl-b degradation is significantly reduced in Cd40 
Reagents
Anti-mouse IgM F(ab') 2 fragment antibodies were purchased from Zymed (San Francisco,CA). Anti-mouse CD40 (clone 3/23) was purchased from BD PharMingen (San Diego, CA). Abs against Cbl-b, Lyn, Fyn, PI3-K (p85), and ubiquitin (Ub), were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Murine B cell isolation kit was obtained from Miltenyi Biotec. (Auburn, CA). HRP-conjugated goat antirabbit IgG or rabbit anti-mouse IgG were purchased from Kirkegaard & Perry Laboratories (Gaithersburg, MD).
B cell isolation and activation

Splenic B cells from WT and Cd40
−/− mice were isolated (purity > 95% as determined by FACS analysis of B220 cell surface expression) using a B cell isolation kit (AutoMACS; Miltenyi Biotec.). Contaminating T cells were less than 1% as determined by CD3 staining. For in vitro activation, B cells (5 × 10 6 /ml) were stimulated for various time periods indicated by F(ab') 2 anti-IgM (2 μg/ml) and/or anti-CD40 (2 μg/ml) monoclonal Abs (mAbs). The cells were lysed in 1% NP-40 lysis buffer [10 mM Tris, pH 7.5, 150 mM NaCl, 2 mM EGTA, 50 mM β-glycerophosphate, 2 mM Na 3 VO 4 , 10 mM NaF, 1 mM dithiothreitol (DTT), 1 mM PMSF, 10 μg/ml leupeptin, and 10 μg/ml aprotinin] or in radioimmunoprecipitation assay (RIPA) buffer (25 mM Tris, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% NP-40, 1% sodium deoxycholate, 1% SDS, 100 μM Na 3 VO 4 , 1 mM NaF, 1 mM PMSF, 10 μg/ml aprotonin, 10 μg/ml leupeptin) where indicated. 
B cell proliferation assay
Immunoprecipitation and western blotting
Protein concentrations in the cell lysates were determined using a bicinchoninic acid assay kit (Pierce, Rockford, IL). Cell lysates were precleared, postnuclear cell lysates were normalized for protein concentration levels, and immunoprecipitated (3 h, 4 o C) with the specific polyclonal Abs or control isotype-matched preimmune immunoglobulin coupled to protein A CL-4B Sepharose (Pharmacia Biotech Inc., Sweden). The immunoprecipitates were resolved on SDS-PAGE and transferred to nitrocellulose membranes (Hybond C Super, Amersham, Piscataway, NJ). In some cases, the cell lysates were blotted with specific Abs. Blots were blocked for 1 h at room temperature in PBS containing 2% BSA and 0.05% Tween-20. Membranes were incubated overnight with specific Abs, then washed 3x in PBS containing 0.05% Tween-20, and detected using HRP-conjugated goat anti-rabbit IgG or rabbit anti-mouse IgG. After 3 washes in PBS containing 0.05% Tween-20, signals were revealed by enhanced chemiluminescence detection system (Amersham) and visualized by autoradiography.
Statistical analysis
Data are expressed as the mean ± SD. Student's t-test is used to determine differences between groups. The level of significance is set as *p < 0.05, **p < 0.01.
Results and discussion
Loss of Cbl-b relieves B cells from the requirement for CD40 costimulation
It has been shown optimal B cell activation requires two signals: one from the BCR and another one from costimulatory receptors [3, 5] . BCR and CD40 synergize in B cell activation [7, 18] where CD40 costimulation may provide the second signal for optimal B cell activation [5] . (Fig. 1B) . These results suggest that loss of Cbl-b uncouples the requirement of CD40 costimulation for B cell proliferation.
CD40 stimulation promotes BCR-induced Cbl-b ubiquitination
We have previously shown that CD28 costimulation of T cells can promote Cbl-b ubiquitination and degradation [15] . To investigate whether this effect on Cbl-b also occurs in CD40-mediated B cell activation, WT splenic B cells were stimulated with F(ab') 2 anti-IgM, with or without anti-CD40. Cell lysates were immunoprecipitated with antiCbl-b and blotted with anti-Ub mAb. Ligation of either IgM or CD40 induced weak Cbl-b ubiquitination ( Fig. 2A) , whereas co-ligation of IgM and CD40 synergistically promoted Cbl-b ubiquitination ( Fig. 2A) . Although Cbl-b was equally expressed in resting B cells from WT and Cd40 −/− mice, Cbl-b degradation kinetics was significantly slower in B cells from Cd40 −/− mice compared to WT B cells in response to IgM stimulation (Fig. 2B) . Cbl-b degradation occurred in a proteasome-dependent pathway since a proteasome inhibitor, lactacystin, completely abrogated Cbl-b degradation (Fig. 2C) .
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Cbl-b degradation is not a general phenomenon associated with CD40 costimulation
It is possible that Cbl-b ubiquitination and degradation is only a general phenomenon associated with CD40 costimulation, and many molecules may also undergo ubiquitination and degradation. To address whether this is the case, WT B cells were stimulated for different times with F(ab') 2 anti-IgM and anti-CD40. At each time-point, cells were collected, and lysed. The cell lysates were blotted with anti-Lyn, anti-Fyn, and anti-PI3-K (p85), revealing that none of these proteins was degraded (Fig. 3) . Our data therefore indicate that ligation of CD40 may favor elimination of the negative regulator Cbl-b, thus allowing optimal activation of B cells.
In summary, our data provide the first evidence for Cbl-b in BCR and CD40-mediated signaling pathways. Cbl-b deficiency uncouples the requirement for CD40 costimulation for B cells proliferation. Moreover, Cbl-b itself undergoes ubiquitination upon BCR stimulation, and CD40 costimulation significantly enhances BCR-induced Cbl-b ubiquitination which correlates with its costimulatory capacity for B cell activation (Fig. 4) . 
